Combined Radiation and PD-L1 Blockade Improved Tumor Control in Mouse Head and Neck Squamous Cell Carcinoma (HNSCC)

被引：2
|
作者：
Kamdem, D. T. [1 ]
Steel, J. C. [2 ]
Wise-Draper, T. [1 ]
Kassing, W. M. [3 ]
Sadraei, N. Hashemi [1 ]
Mierzwa, M. L. [4 ]
Morris, J. C. [1 ]
机构：
[1] Univ Cincinnati, Cincinnati, OH USA
[2] Univ Queensland, Brisbane, Qld, Australia
[3] Univ Hosp, Cincinnati, OH USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 94卷 / 04期
关键词：
D O I：
10.1016/j.ijrobp.2015.12.185
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
248
引用
收藏
页码：928 / 928
页数：1
相关论文
共 50 条
  • [1] PD-L1 expressing circulating tumor cells (CTCs) in patients with head and neck squamous cell carcinoma (HNSCC)
    Strati, Areti
    Koutsodontis, George
    Angelidis, Was
    Sasaki, Clarence
    Avgeris, Margaritis
    Psyrri, Amanda
    Lianidou, Evi S.
    CANCER RESEARCH, 2016, 76
  • [2] Comparison of three PD-L1 immunohistochemical assays in head and neck squamous cell carcinoma (HNSCC)
    de Ruiter, Emma J.
    Mulder, Frans J.
    Koomen, Bregje M.
    Speel, Ernst-Jan
    van den Hout, Mari F. C. M.
    de Roest, Reinout H.
    Bloemena, Elisabeth
    Devriese, Lot A.
    Willems, Stefan M.
    MODERN PATHOLOGY, 2021, 34 (06) : 1125 - 1132
  • [3] The current advances and future directions of PD-1/PD-L1 blockade in head and neck squamous cell carcinoma (HNSCC) in the era of immunotherapy
    Chen, Yunhao
    Ding, Xingchen
    Bai, Xinbin
    Zhou, Zihan
    Liu, Yu
    Zhang, Xianbin
    Yu, Jinming
    Hu, Man
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 120
  • [4] Distinctions in Tumor Microenvironment Between PD-L1 Positive versus Negative Head and Neck Squamous Cell Carcinoma (HNSCC)
    Saini, Kamal S.
    Ko, Heidi C.
    Wallen, Zachary D.
    Green, Michelle F.
    Strickland, Kyle C.
    Previs, Rebecca A.
    Zhang, Shengle
    Conroy, Jeffrey
    Jensen, Taylor J.
    Caveney, Brian J.
    Eisenberg, Marcia
    Vidal, Laura
    Severson, Eric A.
    Ramkissoon, Shakti
    RADIOTHERAPY AND ONCOLOGY, 2024, 192 : S20 - S22
  • [5] Choice of PD-L1 Scoring and Cutoff in Head and Neck Squamous Cell Carcinoma (HNSCC) Trials of Pembrolizumab
    Emancipator, Kenneth
    Juco, Jonathan
    Huang, Lingkang
    Lunceford, Jared
    Cheng, Jonathan
    Ge, Joy
    Gause, Christine
    Swaby, Ramona
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1192 - 1193
  • [6] Choice of PD-L1 Scoring and Cutoff in Head and Neck Squamous Cell Carcinoma (HNSCC) Trials of Pembrolizumab
    Emancipator, Kenneth
    Juco, Jonathan
    Huang, Lingkang
    Lunceford, Jared
    Cheng, Jonathan
    Ge, Joy
    Gause, Christine
    Swaby, Ramona
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1192 - 1193
  • [7] Neoadjuvant PD-1/PD-L1 axis blockade for patients with head and neck squamous cell carcinoma
    Huang, Shuang
    Xiong, Chuang
    Tan, Kui
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2023, 44 (06)
  • [8] Combined Tumor Infiltrating Lymphocytes and PD-L1 Status in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    Haring, Catherine T.
    Smith, Joshua D.
    Dermody, Sarah M.
    Mchugh, Jonathan B.
    Perry, William R.
    Brummel, Collin
    Spector, Matthew E.
    Brenner, J. Chad
    Swiecicki, Paul L.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2025,
  • [9] Proficiency Test PD-L1 Expression in Squamous Cell Carcinomas of the Head and Neck (HNSCC)
    Joehrens, Korinna
    Baretton, Gustavo
    Schildhaus, Hans-Ulrich
    Agaimy, Abbas
    Scheel, Andreas
    Schwammborn, Kristina
    Laenger, Florian
    Tiemann, Markus
    Dietel, Manfred
    PATHOLOGE, 2021, 42 (03): : 352 - 353
  • [10] Relationship between PD-L1 expression and survival in head and neck squamous cell carcinoma (HNSCC) patients (pts)
    Stokes, M.
    Wang, R.
    Wildsmith, S.
    Secrier, M.
    Angell, H. K.
    Barker, C.
    Walker, J.
    Scorer, P.
    Rebelatto, M. C.
    Shire, N.
    ANNALS OF ONCOLOGY, 2017, 28
12345